Armando Santoro
Impact in
- Hepatology top 0.05%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 0.02%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
Papers in
- Oncology 517
- Colorectal Cancer Treatments and Studies 99
- Cancer Immunotherapy and Biomarkers 85
- CAR-T cell therapy research 65
-
- Lymphoma Diagnosis and Treatment 207
- Co-authors
- Gianni BonadonnaPinuccia ValagussaSalvatore SienaEric Van CutsemYves HumbletDavid CunninghamDavid KhayatA. Harstrick
- Journals
- Journal of Clinical Oncology (146 papers)Annals of Oncology (79 papers)Blood (65 papers)European Journal of Cancer (22 papers)Cancers (20 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Armando Santoro
890 papers receiving 33.8k citations
Hit Papers
Peers
Comparison fields: 5 of 165
- Hepatology 5.4k
- Oncology 17.8k
- Pathology and Forensic Medicine 8.8k
- Pulmonary and Respiratory Medicine 13.8k
- Cancer Research 3.8k
Countries citing papers authored by Armando Santoro
This map shows the geographic impact of Armando Santoro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armando Santoro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armando Santoro more than expected).
Fields of papers citing papers by Armando Santoro
This network shows the impact of papers produced by Armando Santoro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armando Santoro. The network helps show where Armando Santoro may publish in the future.
Co-authors
The 25 scholars most cited alongside Armando Santoro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 34 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 11 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 12 | |
| 11 | 2023 | 0 | |
| 12 | 2023 | 7 | |
| 13 | 2023 | 0 | |
| 14 | Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody-drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid Tumors | 2022 | 40 |
| 15 | Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors Hit paper breakdown → | 2021 | 257 |
| 16 | 2018 | 66 | |
| 17 | Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial Hit paper breakdown → | 2018 | 455 |
| 18 | 2016 | 22 | |
| 19 | 2013 | 29 | |
| 20 | 2012 | 330 |
About Armando Santoro
Armando Santoro is a scholar working on Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Hepatology and Genetics, having authored 924 papers that have together received 34.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (207 papers), Lung Cancer Treatments and Mutations (157 papers), Colorectal Cancer Treatments and Studies (99 papers), Hepatocellular Carcinoma Treatment and Prognosis (88 papers), Cancer Immunotherapy and Biomarkers (85 papers), Chronic Lymphocytic Leukemia Research (82 papers), Sarcoma Diagnosis and Treatment (74 papers) and CAR-T cell therapy research (65 papers). The work is most often cited by research in Hepatology (5.4k citations), Oncology (17.8k citations), Pathology and Forensic Medicine (8.8k citations), Pulmonary and Respiratory Medicine (13.8k citations) and Cancer Research (3.8k citations). Armando Santoro has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Gianni Bonadonna, Pinuccia Valagussa, Salvatore Siena, Eric Van Cutsem, Yves Humblet, David Cunningham, David Khayat, A. Harstrick, Harry Bleiberg and Ian Chau. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Blood, European Journal of Cancer and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.